Eurex US has filed an amended antitrust suit against Chicago Board of Trade (CBoT) and Chicago Mercantile Exchange (CME) alleging illegal price cutting, which Eurex claimed has been responsible for the unimpressive performance of its US Treasury products.
The main allegation of the revised suit, filed on 25 March, is against CBoT, for slashing or waiving its exchange fees for US interest rate futures to compete with Eurex US. The suit claims: "as a result, one year after its launch, [Eurex US] has failed to capture a more than trivial portion of the market. Defendants' illegal conduct has deprived consumers of meaningful competition among venues for trading US Treasury...